Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

If passed, anyone who provides or administers a gene-based vaccine to another person would face a penalty of $500 per violation.

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .

Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...

Public health experts discuss lessons learned from the U.S. response to the COVID pandemic, on topics ranging from school ...

Across Indiana, fewer toddlers receive early childhood vaccines on schedule. Doctors are struggling to rebuild trust to prevent dangerous diseases.

A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee ...

Senators heard testimony from Iowans Monday, over a bill that would prohibit anyone in Iowa from administering gene-based vaccines.Right now, the only gene base ...

Iowa Senate Republicans advanced legislation at the beginning of the first funnel week that would prohibit a person from administering a gene-based vaccine to another in ...

Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...